Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions.
Gallo
O
O
Institute of Otolaryngology-Head & Neck Surgery, University of Florence, Firenze, Italy.
Santucci
M
M
Franchi
A
A
D000328:Adult; D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects; D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D002352:Carrier Proteins / Q000096:biosynthesis*; D019941:Cyclin-Dependent Kinase Inhibitor p16; D015536:Down-Regulation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D006965:Hyperplasia / Q000209:etiology / Q000378:metabolism; D007150:Immunohistochemistry; D007822:Laryngeal Neoplasms / Q000209:etiology / Q000378:metabolism*; D007830:Larynx / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011230:Precancerous Conditions / Q000209:etiology / Q000378:metabolism*; D011379:Prognosis; D012907:Smoking / Q000009:adverse effects; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*; D015854:Up-Regulation
D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016159:Tumor Suppressor Protein p53